ARCHIVES

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

March 26, 2004

NCI to Undergo More GAO Probes

July 15, 1977

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

November 20, 1981

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012